RS

Ranu Shukla

Active Director Director DIN 07655925
DIN 07655925 First appointment Jan 2017 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2017
Shareholding value •••• Premium profile

About Ranu Shukla

Data last updated:

Ranu Shukla is a Director at Aarcley Pharmaceutical Private Limited (since 2017). The company operates in Pharma. Aarcley Pharmaceutical Private Limited reported revenue of ₹1.76 Cr (FY 2025).

DIN 07655925
Primary Designation Director
Industry Pharma
First Appointment 12 Jan 2017
Oldest Company Age 9 yrs
Largest company Aarcley Pharmaceutical Private Limited · ₹1.76 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director12 Jan 20172017₹1.76 Cr (FY 2025)Active

Board colleagues of Ranu Shukla

NameDINCompanyDesignation
Vijay Bhushan Shukla07661371Aarcley Pharmaceutical Private LimitedDirector

Directorship timeline

Open interactive timeline →
Aarcley Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Ranu Shukla

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ranu Shukla

Ranu Shukla currently holds 1 directorship: Aarcley Pharmaceutical Private Limited (Director, since 12 Jan 2017, revenue ₹1.76 Cr (FY 2025)).

Ranu Shukla was first appointed on 12 Jan 2017 as Director at Aarcley Pharmaceutical Private Limited.

The current boards of Ranu Shukla's companies include Vijay Bhushan Shukla (Aarcley Pharmaceutical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available